G16R (p.Gly16Arg) variant of CDK2 (Cyclin-dependent kinase 2)
G16R (p.Gly16Arg) in CDK2 (Cyclin-dependent kinase 2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.73 / 1. The record also includes structural context.
G16R (p.Gly16Arg) variant details
- p.Gly16Arg
- rs113816950
- NCI-TCGA Cosmic COSV9990
- Ensembl rs113816950
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.731
- AlphaMissense 1.00
- MetaLR 0.65
- MetaSVM 0.62
- PolyPhen-2 1.00
- SIFT 0.00
- MutPred 0.73
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available